Abstract
The cyclic peptide OS1 (amino acid sequence: CTERMALHNLC), which has a disulfide bond between both termini cysteine residues, inhibits complex formation between the platelet glycoprotein Ib alpha (GPIb alpha) and the von Willebrand factor (vWF) by forming a complex with GPIb alpha. To study the binding mechanism between GPIb alpha and OS1 and, therefore, the inhibition mechanism of the protein-protein GPIb alpha-vWF complex, we have applied our multicanonical molecular dynamics (McMD)-based dynamic docking protocol starting from the unbound state of the peptide. Our simulations have reproduced the experimental complex structure, although the top-ranking structure was an intermediary one, where the peptide was bound in the same location as in the experimental structure; however, the beta-switch of GPIb alpha attained a different conformation. Our analysis showed that subsequent refolding of the beta-switch results in a more stable binding configuration, although the transition to the native configuration appears to take some time, during which OS1 could dissociate. Our results show that conformational changes in the beta-switch are crucial for successful binding of OS1. Furthermore, we identified several allosteric binding sites of GPIb alpha that might also interfere with vWF binding, and optimization of the peptide to target these allosteric sites might lead to a more effective inhibitor, as these are not dependent on the beta-switch conformation.
Funding Information
  • Japan Agency for Medical Research and Development (23ae0121028h0003)
  • Japan Society for the Promotion of Science (JP20H03229)

This publication has 58 references indexed in Scilit: